Related Experiment Video
Updated: Jun 13, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Molecular pathology in early hepatocarcinogenesis
Kathryn Effendi1, Michiie Sakamoto
1Department of Pathology, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan.
Oncology
|April 15, 2010
Summary
Researchers identified key molecular signatures, including heat-shock protein 70 and Bmi-1, in early hepatocellular carcinoma (HCC). These findings offer new insights into the early stages of liver cancer development.
Area of Science:
- Hepatology
- Molecular Oncology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) is a common malignancy with a multistage development process.
- Early diagnosis of small lesions as dysplastic nodules or early HCC is crucial for understanding cancer progression.
- The molecular mechanisms underlying early hepatocarcinogenesis are not well understood due to limited models and sample availability.
Purpose of the Study:
- To identify molecular signatures associated with early hepatocellular carcinoma.
- To investigate the role of specific genes in the initial stages of liver cancer development.
- To provide new insights into the molecular pathology of early hepatocarcinogenesis.
Main Methods:
- Gene expression profiling was employed to identify molecular markers.
- Analysis focused on identifying overexpressed proteins in early HCC samples.
- Correlation between identified molecular markers and other relevant genes was investigated.
Main Results:
- Overexpression of heat-shock protein 70 and cyclase-associated protein 2 were identified as early HCC signatures.
- The stemness gene Bmi-1 was found to be overexpressed in early HCC.
- Bmi-1 overexpression correlated with ATP-binding cassette transporter B1 expression.
Conclusions:
- Heat-shock protein 70, cyclase-associated protein 2, and Bmi-1 represent potential molecular markers for early HCC.
- These findings contribute to a better understanding of the molecular mechanisms driving early liver cancer.
- Further research is needed to fully elucidate the roles of these candidates in hepatocarcinogenesis.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...